Literature DB >> 17065496

A new 3D monitor-based random-dot stereotest for children.

Armin Breyer1, Xiaoyi Jiang, Adrian Rütsche, Daniel S Mojon.   

Abstract

PURPOSE: Objective testing for random-dot stereovision in preverbal children requires some type of dissociating glasses. Drawbacks of such methods are the alteration of natural visual conditions and sometimes nonacceptance of the glasses. For this reason, a new, natural method for random-dot stereopsis measurement was developed and tested.
METHODS: Random-dot circles (diameter 10 cm, crossed disparity of 0.34 degrees ) were generated on an autostereoscopic display and presented to 18 normal children (mean age, 5.1 +/- 1.1 years), 8 with anisometropic amblyopia (mean age, 4.9 +/- 1.3 years), 14 with infantile essential esotropia (mean age, 5.3 +/- 0.7 years), and 16 with primary microstrabismus (mean age, 5.2 +/- 1.4 years). While the position of the stimulus randomly changed among four possible locations, eye positions were recorded by infrared photo-oculography. If two or more consecutive saccades ends corresponded to the stimulus coordinates, a positive response was assumed. The results with the new test were compared with the ability to recognize the Lang I random-dot stereotest.
RESULTS: Twenty-four of 26 Lang I-positive children had positive responses (sensitivity of 92.3%), 29 of 30 Lang I-negative children had negative three-dimensional (3D) stimulus responses (specificity, 96.7%). The positive predictive value of the new test was 0.96 (95% CI, 0.79-0.99); the negative predictive value, 0.94 (95% CI, 0.78-0.99); and the overall accuracy, 0.95 (95% CI, 0.85-0.99).
CONCLUSIONS: This new 3D monitor-based test allows objective assessment of random-dot stereopsis in children older than 3 years.

Entities:  

Mesh:

Year:  2006        PMID: 17065496     DOI: 10.1167/iovs.06-0238

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Performance of a new, 3D-monitor based random-dot stereotest for children under 4 years of age.

Authors:  Birgitta Kriegbaum-Stehberger; Xiaoyi Jiang; Daniel S Mojon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-03       Impact factor: 3.117

2.  Effects of interpupillary distance on stereoacuity: the Frisby Davis distance stereotest versus a 3-dimensional distance stereotest.

Authors:  Youngsub Eom; Jong-Suk Song; Soh-Eun Ahn; Su-Yeon Kang; Young-Woo Suh; Jaeryung Oh; Seung-Hyun Kim; Hyo Myung Kim
Journal:  Jpn J Ophthalmol       Date:  2013-07-05       Impact factor: 2.447

Review 3.  Stereo vision and strabismus.

Authors:  J C A Read
Journal:  Eye (Lond)       Date:  2014-12-05       Impact factor: 3.775

4.  [Nintendo 3DS: technology, physiology and possible risks for children's eyes].

Authors:  A Pallas; C H Meyer; D Mojon
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

5.  ASTEROID: A New Clinical Stereotest on an Autostereo 3D Tablet.

Authors:  Kathleen Vancleef; Ignacio Serrano-Pedraza; Craig Sharp; Gareth Slack; Carla Black; Therese Casanova; Jess Hugill; Sheima Rafiq; James Burridge; Vito Puyat; Josee Ewane Enongue; Henry Gale; Hannah Akotei; Zoe Collier; Helen Haggerty; Kathryn Smart; Christine Powell; Kate Taylor; Michael P Clarke; Graham Morgan; Jenny C A Read
Journal:  Transl Vis Sci Technol       Date:  2019-02-28       Impact factor: 3.283

6.  New stereoacuity test using a 3-dimensional display system in children.

Authors:  Sang Beom Han; Hee Kyung Yang; Jonghyun Kim; Keehoon Hong; Byoungho Lee; Jeong-Min Hwang
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

7.  An Evaluation of the Agreement Between a Computerized Stereoscopic Game Test and the TNO Stereoacuity Test.

Authors:  Juan Antonio Portela-Camino; Santiago Martín-González; Javier Ruiz-Alcocer; Igor Illarramendi-Mendicute; Rafaela Garrido-Mercado
Journal:  Clin Optom (Auckl)       Date:  2021-07-05

8.  Screening for Stereopsis of Children Using an Autostereoscopic Smartphone.

Authors:  Yanhui Yang; Huang Wu
Journal:  J Ophthalmol       Date:  2019-10-31       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.